Following on from the posts about AMPK activators, here are some points which may be of interest.
Reading about Berberine and Conjugated Linoleic Acid (both AMPK activators), I read that CD36 (a receptor which binds fatty acids and oxidized LDL among other things) is upregulated by these substances. This would appear to lead towards fatty liver and atherosclerosis.
https://www.osti.gov...ocase-cd36-mice
https://www.ncbi.nlm...les/PMC3160137/
https://www.scienced...041008X16303957
However, there are conflicting reports for both substances, as positive studies for atherosclerosis can also be found.
https://www.ncbi.nlm...les/PMC4261588/
https://bpspubs.onli....1111/bcp.12948
AMPK activation may also decrease cholesterol production, which would explain the reduced plaque formation in cases of supplementation of activators.
https://journals.plo...al.pone.0124951
CD36 appears to have a modulatory effect on AMPK. If CD36 is blocked or downregulated, AMPK is activated. In theory, with CD36 blocking and AMPK activation, atherosclerosis could be reversed.
ttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0037633
There are some available CD36 inhibitors.
https://journals.sag...087057109359686
Rosmarinic acid, from Rosemary, Lemon Balm, Sage etc., being one.
https://www.jmcc-onl...0065-5/fulltext
Edited by Snapper, 26 October 2021 - 12:39 PM.